will collaborate with a California firm to develop kits that measure the impact of drugs on cells.
"The software and reagents in these kits will allow our customers to quantify microscopic effects of drug treatments," said Ben Buehrer, director of research and development at Zen-Bio. "This technology has practical application for the discovery and development of drugs to treat obesity and type II diabetes."
Zen-Bio and its partner Vala Sciences received a Phase 1 Small Business Innovative Research grant from the National Institutes of Health to help fund the project.
Zen-Bio produces normal human cells and cell extracts. It also offers contract assay services and research kits.
Copyright 2024 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
